Mml Investors Services, LLC 9 Meters Biopharma, Inc. Transaction History

Mml Investors Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.52 - $1.0 $10,660 - $20,500	-20,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $425 - $665	500 Added 2.5%	20,500 $20,000
Q1 2021 May 14, 2021	BUY	$0.84 - $2.16 $16,800 - $43,200	20,000 New	20,000 $23,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.